Page last updated: 2024-09-03

cholestyramine resin and Thyrotoxicosis

cholestyramine resin has been researched along with Thyrotoxicosis in 6 studies

*Thyrotoxicosis: A hypermetabolic syndrome caused by excess THYROID HORMONES which may come from endogenous or exogenous sources. The endogenous source of hormone may be thyroid HYPERPLASIA; THYROID NEOPLASMS; or hormone-producing extrathyroidal tissue. Thyrotoxicosis is characterized by NERVOUSNESS; TACHYCARDIA; FATIGUE; WEIGHT LOSS; heat intolerance; and excessive SWEATING. [MeSH]

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (33.33)	24.3611
2020's	2 (33.33)	2.80

Authors

Authors	Studies
Ali, A; Mandal, S; Maryam, M; Rummaan, A; Saeed, T	1
Bellastella, G; Esposito, K; Giovanella, L; Maiorino, MI; Scappaticcio, L	1
Bornemann, M; Lin, D; Suwantarat, N	1
Bennet, A; Caron, P; Kahina, B; Maiza, JC	1
Burman, KD; Solomon, BL; Wartofsky, L	1
Burman, KD; Cranston, T; Porter, L; Sfikakis, PP; Smallridge, RC; Solomon, BL; Tsokos, GC	1

Reviews

1 review(s) available for cholestyramine resin and Thyrotoxicosis

Article	Year
Medical treatment of thyrotoxicosis. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2021, Volume: 65, Issue:2 Topics: Adrenal Cortex Hormones; Antithyroid Agents; Cholestyramine Resin; Dose-Response Relationship, Drug; Humans; Iodides; Lithium; Perchlorates; Signal Transduction; Thyrotoxicosis	2021

Article

Year

Medical treatment of thyrotoxicosis.

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2021, Volume: 65, Issue:2

Topics: Adrenal Cortex Hormones; Antithyroid Agents; Cholestyramine Resin; Dose-Response Relationship, Drug; Humans; Iodides; Lithium; Perchlorates; Signal Transduction; Thyrotoxicosis

2021

Trials

2 trial(s) available for cholestyramine resin and Thyrotoxicosis

Article	Year
Adjunctive cholestyramine therapy for thyrotoxicosis. Clinical endocrinology, 1993, Volume: 38, Issue:1 Topics: Adult; Atenolol; Chemotherapy, Adjuvant; Cholestyramine Resin; Double-Blind Method; Female; Graves Disease; Humans; Male; Methimazole; Middle Aged; Thyroid Hormones; Thyrotoxicosis	1993
Soluble interleukin-2 receptor is a thyroid hormone-dependent early-response marker in the treatment of thyrotoxicosis. Clinical and diagnostic laboratory immunology, 1997, Volume: 4, Issue:5 Topics: Antithyroid Agents; Biomarkers; Cholestyramine Resin; E-Selectin; Female; Graves Disease; Humans; Intercellular Adhesion Molecule-1; Male; Methimazole; Multivariate Analysis; Randomized Controlled Trials as Topic; Receptors, Interleukin-2; Thyroid Hormones; Thyrotoxicosis	1997

Article

Year

Adjunctive cholestyramine therapy for thyrotoxicosis.

Clinical endocrinology, 1993, Volume: 38, Issue:1

Topics: Adult; Atenolol; Chemotherapy, Adjuvant; Cholestyramine Resin; Double-Blind Method; Female; Graves Disease; Humans; Male; Methimazole; Middle Aged; Thyroid Hormones; Thyrotoxicosis

1993

Soluble interleukin-2 receptor is a thyroid hormone-dependent early-response marker in the treatment of thyrotoxicosis.

Clinical and diagnostic laboratory immunology, 1997, Volume: 4, Issue:5

Topics: Antithyroid Agents; Biomarkers; Cholestyramine Resin; E-Selectin; Female; Graves Disease; Humans; Intercellular Adhesion Molecule-1; Male; Methimazole; Multivariate Analysis; Randomized Controlled Trials as Topic; Receptors, Interleukin-2; Thyroid Hormones; Thyrotoxicosis

1997

Other Studies

3 other study(ies) available for cholestyramine resin and Thyrotoxicosis

Article	Year
Resistant type 2 amiodarone-induced thyrotoxicosis responsive to cholestyramine as an adjunctive therapy. Clinical medicine (London, England), 2021, Volume: 21, Issue:5 Topics: Amiodarone; Anti-Arrhythmia Agents; Cholestyramine Resin; Humans; Thyrotoxicosis	2021
Cholestyramine for thyrotoxicosis? The Journal of family practice, 2013, Volume: 62, Issue:4 Topics: Adult; Antithyroid Agents; Cholestyramine Resin; Female; Humans; Interferon-alpha; Thyrotoxicosis; Treatment Outcome	2013
[Thyrotoxicosis: adjunctive cholestyramine therapy]. Presse medicale (Paris, France : 1983), 2010, Volume: 39, Issue:11 Topics: Adult; Anion Exchange Resins; Cholestyramine Resin; Female; Humans; Thyrotoxicosis	2010